Why the study?
Does low sodium intake reduce cardiovascular disease incidence compared to moderate intake?
Does low sodium intake reduce cardiovascular disease incidence compared to moderate intake?
This review highlights the lack of definitive RCT data for low sodium intake on cardiovascular events and points out observational evidence suggesting potential harm, emphasizing the need for large-scale randomized trials.
Answers are grounded in this paper and cite their sources.
Guideline low-sodium targets lack RCT support; J-shaped cohorts challenge benefits and leave optimal intake unresolved.
Effective population-based interventions are required to reduce the global burden of cardiovascular disease (CVD). Reducing salt intake has emerged as a leading target, with many guidelines recommending sodium intakes of 2.3 g/day or lower. These guideline thresholds are based largely on clinical trials reporting a reduction in blood pressure with low, compared with moderate, intake. However, no large-scale randomized trials have been conducted to determine the effect of low sodium intake on CV events. Prospective cohort studies evaluating the association between sodium intake and CV outcomes have been inconsistent and a number of recent studies have reported an association between low sodium intake (in the range recommended by current guidelines) and an increased risk of CV death. In the largest of these studies, a J-shaped association between sodium intake and CV death and heart failure was found. Despite a large body of research in this area, there are divergent interpretations of these data, with some advocating a re-evaluation of the current guideline recommendations. In this article, we explore potential reasons for the differing interpretations of existing evidence on the association between sodium intake and CVD. Similar to other areas in prevention, the controversy is likely to remain unresolved until large-scale definitive randomized controlled trials are conducted to determine the effect of low sodium intake (compared to moderate intake) on CVD incidence.
No takes yet. Share an insight, caveat, or question.
O’Donnell et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: